Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 1/2021

01-03-2021 | Letter to the Editor

Predatory Publishing—the Early Career Researcher’s View

Author: Deep Chakrabarti

Published in: Journal of Gastrointestinal Cancer | Issue 1/2021

Login to get access

Excerpt

The review by Yosef Mohammed-Azzam Zakout touches a crucial point, and predatory publishing is a rampant problem in academia today [1]. A substantial amount is known about how this model exploits scientists and researchers, particularly in developing nations, in the name of open access [2, 3]. As unfortunate as it is, a majority of early career researchers publishing in predatory journals are unaware of what it means. Students under pressure to publish their work fall prey to editorial houses that often spam users with emails about new journals and conferences. The journal names are a close match to “real” journals. To the unaccustomed eye, these differences are not easy to make out. Even as India looks to curb down on this menace [4, 5], one wonders what more can be done at a ground level. The consensus of a definition and the creation of an online portal reflect much needed and welcome initial steps [6]. However, as a young clinician-researcher, a few further suggestions can be offered. …
Literature
2.
go back to reference Eriksson S, Helgesson G. The false academy: predatory publishing in science and bioethics. Med Health Care Philos. 2017;20:163–70.CrossRef Eriksson S, Helgesson G. The false academy: predatory publishing in science and bioethics. Med Health Care Philos. 2017;20:163–70.CrossRef
3.
go back to reference Beall J. Predatory publishers are corrupting open access. Nature. 2012;489:179.CrossRef Beall J. Predatory publishers are corrupting open access. Nature. 2012;489:179.CrossRef
4.
go back to reference Priyadarshini S. India targets universities in predatory-journal crackdown. Nature. 2018;560(7720):537–8.CrossRef Priyadarshini S. India targets universities in predatory-journal crackdown. Nature. 2018;560(7720):537–8.CrossRef
5.
go back to reference Patwardhan B. Why India is striking back against predatory journals. Nature. 2019;571(7763):7.CrossRef Patwardhan B. Why India is striking back against predatory journals. Nature. 2019;571(7763):7.CrossRef
6.
go back to reference Grudniewicz A, Moher D, Cobey KD, Bryson GL, Cukier S, Allen K, et al. Predatory journals: no definition, no defence. Nature. 2019;576:210–2.CrossRef Grudniewicz A, Moher D, Cobey KD, Bryson GL, Cukier S, Allen K, et al. Predatory journals: no definition, no defence. Nature. 2019;576:210–2.CrossRef
8.
go back to reference Clark J, Smith R. Firm action needed on predatory journals. BMJ. 2015;350:h210.CrossRef Clark J, Smith R. Firm action needed on predatory journals. BMJ. 2015;350:h210.CrossRef
9.
Metadata
Title
Predatory Publishing—the Early Career Researcher’s View
Author
Deep Chakrabarti
Publication date
01-03-2021
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2021
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-020-00458-0

Other articles of this Issue 1/2021

Journal of Gastrointestinal Cancer 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.